Skip to content
March 29, 2024

Equity.Guru

Investment information for the new generation

Search

GSK.NYSE

GlaxoSmithKline (GSK.NYSE) today announced positive headline results from five studies of the Phase 3 ASCEND program, evaluating the efficacy and safety profile of daprodustat, an investigational oral hypoxia-inducible factor…
Pure Extracts Technologies (PULL.C) signed an letter of intent (LOI) with mushroom-derived wellness products company, Nutraceutical Medicine Company, to help springboard Pure’s expansion into the functional mushroom sector and…
“More than 4 million adults experience chronic daily migraine – with at least 15 migraine days per month,” states The Migraine Research Foundation, “It affects 39 million people in the U.S….
“A once-a-day pill that reduces HbA1c and improves time in range with continuous glucose monitoring, without increasing hypoglycemia or any signal for adverse events, is a big win for…
A Harvard University Study calculates the economic burden from diabetes at about $1.3 trillion, or 1.8% of global GDP….